DuneGlass Capital announced today that its Doctor Equity™ MSO launched for medical practice owners across a variety of specialties.
The Doctor Equity™ MSO model flips the script on the traditional MSO by morphing doctor practices into private equity vehicles, according to a press release. Doctors who adopt the Doctor Equity™ model retain the vast majority of their ownership and all clinical control.
The four companies currently utilizing DuneGlass Capital’s Doctor Equity™ model – Allied OMS, BGS Alliance, LifeFlow Partners, and Phase 1 Equity – now work with management teams who have decades of private equity experience and deliver negotiating power, industry insights, more equitable contracts, and economics.
“We’re showing practice owners a new path to getting the support and resources they need to compete in today’s market,” says Dan Hosler, Managing Partner at DuneGlass Capital and co-Founder of the Doctor Equity™ model. “Our MSO model is differentiated because the clinical shareholders 1) retain majority share of ownership, 2) are governed by a doctor-led Board of Directors, 3) benefit from proprietary private equity insights to optimize and monetize the value of their practices and 4) maintain clinical and cultural autonomy at the practice level.” Read more.
